Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir Intensification in HIV Patients with Suboptimal CD4+ Response
NCT00631449Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Raltegravir with Placebo (2 arms). Primary endpoint: Number of Participants With Undetectable Plasma HIV-1 RNA at 12 weeks. Started Feb 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00631449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631449.